BioDelivera YC F26

Today we are launching @BioDelivera a programmable drug delivery platform that delivers therapies only to diseased cells enabling cures for every disease. 🎯🧪 Less than 3% of an injected therapy reaches diseased cells. The rest ends up in healthy organs. At @BioDelivera we want to change that, our mission is to make every therapy accessible to patients. Happy to build with @ikeda_trashi this exciting technology! Reach out at founders@biodelivera.com

Me and my twin sister @ikeda_trashi, built @BioDelivera on the foundation of five years of PhD research to break the limits of drug delivery and enable cures for every disease. 💥 Today, less than 3% of injected therapy reaches diseased cells. Most of it spreads throughout the body, exposing healthy organs to drugs they don't need. Poor targeting causes toxicity, makes patients sick, and forces lower doses that limit how effective treatments can be. We cherry-picked the finest elements and created Guided Chimeric Vehicles (GCVs). 🦠 These chimeric nanoparticles are specifically designed to bind to the desired cell with no off-target to healthy organs. The platform is programmable to target cells across cancer, brain, muscles, and other hard-to-reach organs, including cells involved in age-related diseases.🚀 What is your biggest struggle you are facing right now in drug delivery?

Happy to pitch with @ikeda_trashii our platform technology for cancer treatment, and yes we won the 1st place in student track at @BigIdeaUTD YAY So excited for BioDelivera and what we will bring to the world! #biodelivera #bigideautd

At @draper_u Call to Build Event we had the opportunity to listen to amazing speakers and pitches!! Bonus points was meeting with @TimDraper again!!